VIDEO: Apalutamide’s tolerability in prostate cancer patients

19 May 2025
Dr. Darren Poon
Dr. Darren PoonSpecialist in Clinical Oncology ; Hong Kong Sanatorium & Hospital, Chinese University of Hong Kong ; Hong Kong
Dr. Darren Poon
Dr. Darren Poon Specialist in Clinical Oncology ; Hong Kong Sanatorium & Hospital, Chinese University of Hong Kong ; Hong Kong
Dr Darren Poon, Specialist in Clinical Oncology at Hong Kong Sanatorium & Hospital and Honorary Clinical Associate Professor at the Chinese University of Hong Kong, discusses apalutamide’s tolerability in prostate cancer patients.


Disclaimer
This video is supported by Johnson & Johnson (Hong Kong) Ltd. 
CP-516441 April 2025

Related MIMS Drugs